BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 7916335)

  • 1. New anxiolytics in development.
    Mosconi M; Chiamulera C; Recchia G
    Int J Clin Pharmacol Res; 1993; 13(6):331-44. PubMed ID: 7916335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of generalized anxiety: new pharmacologic approaches].
    Boulenger JP
    Encephale; 1995; 21(6):459-66. PubMed ID: 8674471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New anxiolytic drugs: methodological issues].
    Ginestet D; Corruble E
    Encephale; 1993; 19(6):627-37. PubMed ID: 12404782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New molecular targets for antianxiety interventions.
    Gorman JM
    J Clin Psychiatry; 2003; 64 Suppl 3():28-35. PubMed ID: 12662131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anxioselective anxiolytics: can less be more?
    Basile AS; Lippa AS; Skolnick P
    Eur J Pharmacol; 2004 Oct; 500(1-3):441-51. PubMed ID: 15464051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GABAA receptors as targets for novel anxiolytic drugs.
    Rupprecht R; Eser D; Zwanzger P; Möller HJ
    World J Biol Psychiatry; 2006; 7(4):231-7. PubMed ID: 17071543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A new group of anxiolytic drugs with a mechanism of action different from that of benzodiazepine derivatives].
    Kostowski W; Płaźnik A
    Pol Tyg Lek; 1988 Dec 19-26; 43(51-52):1647-9, 1683. PubMed ID: 2908340
    [No Abstract]   [Full Text] [Related]  

  • 8. Future directions in anxiolytic pharmacotherapy.
    Kunovac JL; Stahl SM
    Psychiatr Clin North Am; 1995 Dec; 18(4):895-909. PubMed ID: 8748388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Approaches to developing new anxiolytics and antidepressants.
    Dubovsky SL
    J Clin Psychiatry; 1993 May; 54 Suppl():75-83. PubMed ID: 8099580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutamate receptor ligands as anxiolytics.
    Chojnacka-Wójcik E; Kłodzinska A; Pilc A
    Curr Opin Investig Drugs; 2001 Aug; 2(8):1112-9. PubMed ID: 11892923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mechanism of action, indications and abuse of benzodiazepine anxiolytic drugs].
    Goffinet S
    Ann Med Psychol (Paris); 1993 Jan; 151(1):47-63. PubMed ID: 7905724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonbenzodiazepine anxiolytics: clinical usefulness.
    Rickels K
    J Clin Psychiatry; 1983 Nov; 44(11 Pt 2):38-44. PubMed ID: 6139368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The benzodiazepine receptor: the enigma of the endogenous ligand].
    Pélissolo A
    Encephale; 1995; 21(2):133-40. PubMed ID: 7781584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recent progress in development of psychotropic drugs (1)--Anti-anxiety drugs].
    Kudo Y; Kudo T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Apr; 15(2):75-86. PubMed ID: 7796324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of GABAA receptor subtypes to the anxiolytic-like, motor, and discriminative stimulus effects of benzodiazepines: studies with the functionally selective ligand SL651498 [6-fluoro-9-methyl-2-phenyl-4-(pyrrolidin-1-yl-carbonyl)-2,9-dihydro-1H-pyridol[3,4-b]indol-1-one].
    Licata SC; Platt DM; Cook JM; Sarma PV; Griebel G; Rowlett JK
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1118-25. PubMed ID: 15687371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translocator protein (18 kDa) as a target for novel anxiolytics with a favourable side-effect profile.
    Nothdurfter C; Rammes G; Baghai TC; Schüle C; Schumacher M; Papadopoulos V; Rupprecht R
    J Neuroendocrinol; 2012 Jan; 24(1):82-92. PubMed ID: 21609361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacology of new anxiolytics acting on 5-HT neurones.
    Marsden CA
    Postgrad Med J; 1990; 66 Suppl 2():S2-6. PubMed ID: 1975437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug mechanisms in anxiety.
    Bourin M; Hascoët M
    Curr Opin Investig Drugs; 2001 Feb; 2(2):259-65. PubMed ID: 11816841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacotherapy with benzodiazepines: basic principles and new developments].
    Möhler H
    Praxis (Bern 1994); 1998 Feb; 87(6):186-90. PubMed ID: 9531812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CR 2945: a novel CCKB receptor antagonist with anxiolytic-like activity.
    Revel L; Mennuni L; Garofalo P; Makovec F
    Behav Pharmacol; 1998 May; 9(3):183-94. PubMed ID: 9832933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.